Azenta Life Sciences Competitors and Similar CompaniesClear all

Azenta Life Sciences's competitors and similar companies include Novogene, Integrated DNA Technologies and GenScript.

	Azenta Life Sciences Azenta Life Sciences (formerly known as Brooks Automation) is a provider of biological and chemical compound sample exploration and management capabilities for the life sciences industry.	Novogene Novogene (北京诺禾致源科技股份有限公司) is a company specializing in genomics and bioinformatics research solutions.	Integrated DNA Technologies Integrated DNA Technologies (IDT) is a company that develops, manufactures, and markets nucleic acid products.	GenScript Genscript Biotech is a biotech company focusing on early drug discovery and development services.
Founding Date	Founding Date 1978	Founding Date 2011	Founding Date 1987	Founding Date 2002
Type	Type Public	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare automation biotech life sciences medical devices procurement	Tags Healthcare biotech genetics life sciences medical diagnostics pharma	Tags Manufacturing & Industrial bioengineering biotech life sciences pharma	Tags Technology biotech contractor drug development life sciences
Locations	Locations Burlington, US HQ Beijing, CN Guangzhou, CN Shanghai, CN Shanghai, CN Suzhou, CN Tianjin, CN see more	Locations Beijing, CN HQ Planegg, DE Hong Kong, HK Tokyo, JP Seoul, KR Singapore, SG Cambridge, GB see more	Locations Coralville, US HQ Glen Waverley, AU Leuven, BE Shanghai, CN Tokyo, JP Hanam Si, KR Singapore, SG see more	Locations Nanjing, CN HQ Tokyo, JP Seoul, KR Rijswijk, NL Singapore, SG Oxford, GB Piscataway, US
Employees	Employees 3,5009% increase	Employees 2,2023% increase	Employees 1,7351% decrease	Employees 5,568
Financial
Revenue (est.)	Revenue (est.) $593.8m (FY, 2025)	Revenue (est.) ¥2.2b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $959.5m (FY, 2025)
Cost of goods	Cost of goods $323.5m (FY, 2025)	Cost of goods ¥1.3b (FY, 2025)	Cost of goods N/A	Cost of goods $332.3m (FY, 2025)
Gross profit	Gross profit $270.3m (FY, 2025)	Gross profit ¥934.7m (FY, 2025)	Gross profit N/A	Gross profit $650.8m (FY, 2025)
Net income	Net income ($55.8m) (FY, 2025)	Net income ¥171.5m (FY, 2025)	Net income N/A	Net income ($532.4m) (FY, 2025)
Operating ⚠
Countries	Countries 180 (Q1, 2023)	Countries N/A	Countries 100 (Apr, 2023)	Countries 100 (FY, 2022)
Remaining Performance Obligations	Remaining Performance Obligations $89.8m (Q1, 2023)	Remaining Performance Obligations N/A	Remaining Performance Obligations N/A	Remaining Performance Obligations $43.7m (FY, 2022)